Anxiety: Part 1

In the beginning, you really don't know that your lymphoma diagnosis will include dealing with anxiety. It will take many forms over time. During diagnosis it is anxiety over what will happen. Then when in treatment a new form - treatment anxiety, when you associate negative treatment reactions (side effects) with the treatment - you can actually feel sick before treatment, for example just walking into the treatment center. Things subside considerably when the medical team announces positive results and hopefully remission ("cancer gone!"). But the last form of anxiety can last years: checkup anxiety makes you dread the checkups because no one wants bad news. I have lived 10 years with that one.



Fortunately, the support of your loved ones and caregiver(s) can help considerably. Attending cancer support groups (live or online) or seeing a therapist can also dramatically help. So don't go it alone - find your niche and let it out.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap